Author:
Kolik L. G.,Nadorova A. V.,Tsorin I. B.,Barchukov V. V.,Mokrov G. V.,Likhosherstov A. M.,Gudasheva T. A.,Kryzhanovskii S. A.,Durnev A. D.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference15 articles.
1. Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, Kryzhanovskii SA. Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction. Bull. Exp. Biol. Med. 2019;167(4):460-463. doi: https://doi.org/10.1007/s10517-019-04549-2
2. Kolik LG, Nadorova AV, Gudasheva TA, Martyanov VA, Seredenin SB. Dipeptide cholecystokinin-4 analog attenuates anxiety in “high-emotional” mice BALB/C and in ethanolwithdrawn rats: comparison with phenazepam. Farmakokinetika Farmakodinamika. 2017;(2):19-24. Russian.
3. Kolik LG, Nadorova AV, Stolyaruk VN, Miroshkina IA, Tsorin IB, Kryzhanovskii SA. Anxiolytic Properties of Trimetazidine in Experimental Models of Increased Anxiety. Bull. Exp. Biol. Med. 2017;162(5):643-646. doi: https://doi.org/10.1007/s10517-017-3677-2
4. Mokrov GV, Likhosherstov AM, Barchukov VV, Stolyaruk VN, Tsorin IB, Vititnova MB, Kryzhanovskiy SA, Gudasheva TA. Study of methoxy-group position influence on compound ALM-802 cardiotropic activity. Farmakokinetika Farmakodinamika. 2019;(1):6-11. Russian.
5. Abdel-Salam OM, El-Batran S. Pharmacological investigation of trimetazidine in models of inflammation, pain and gastric injury in rodents. Pharmacology. 2005;75(3):122-132. doi: https://doi.org/10.1159/000088211